Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
16.76
+0.34 (2.07%)
Nov 5, 2024, 4:00 PM EST - Market closed
Tyra Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 5, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 885 | 596 | 318 | 572 | - | - |
| Market Cap Growth | 15.88% | 87.61% | -44.42% | - | - | - |
| Enterprise Value | 518 | 387 | 57 | 260 | - | - |
| Last Close Price | 16.76 | 13.85 | 7.60 | 14.07 | - | - |
| PE Ratio | - | -8.56 | -5.75 | -7.37 | - | - |
| PB Ratio | 2.35 | 2.92 | 1.23 | 1.90 | - | - |
| P/FCF Ratio | -13.07 | -11.71 | -6.25 | -23.43 | - | - |
| P/OCF Ratio | -13.34 | -11.89 | -6.32 | -24.09 | - | - |
| EV/EBITDA Ratio | -4.88 | -4.86 | -0.98 | -9.95 | - | - |
| EV/EBIT Ratio | -4.86 | -4.84 | -0.97 | -9.90 | - | - |
| EV/FCF Ratio | -7.22 | -7.60 | -1.13 | -10.66 | - | - |
| Debt / Equity Ratio | 0.02 | 0.03 | 0.01 | 0.00 | 0.01 | -0.05 |
| Debt / FCF Ratio | -0.10 | -0.13 | -0.05 | -0.05 | -0.02 | -0.10 |
| Quick Ratio | 36.19 | 13.32 | 44.06 | 83.57 | 8.19 | 0.02 |
| Current Ratio | 36.46 | 13.80 | 45.13 | 84.09 | 8.22 | 0.02 |
| Return on Equity (ROE) | -26.50% | -29.92% | -19.77% | -16.65% | -201.38% | - |
| Return on Assets (ROA) | -18.57% | -20.31% | -12.86% | -10.18% | -70.27% | - |
| Return on Capital (ROIC) | -19.03% | -21.21% | -13.07% | -10.36% | -120.22% | - |
| Earnings Yield | -9.20% | -11.59% | -17.41% | -4.60% | - | - |
| FCF Yield | -7.26% | -8.54% | -16.00% | -4.27% | - | - |
| Buyback Yield / Dilution | -16.28% | -1.96% | -203.94% | -793.58% | 41.81% | - |
| Total Shareholder Return | -16.28% | -1.96% | -203.94% | -793.58% | 41.81% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.